Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-326-3 | CAS number: 105-74-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Apparently well conducted study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- study was conducted with an accepted guideline at the time, before LLNA method was adopted
Test material
- Reference substance name:
- Dilauroyl peroxide
- EC Number:
- 203-326-3
- EC Name:
- Dilauroyl peroxide
- Cas Number:
- 105-74-8
- Molecular formula:
- C24H46O4
- IUPAC Name:
- dodecanoyl dodecaneperoxoate
- Details on test material:
- The test substance DILAUROYL PEROXIDE
Documentation supplied by the Sponsor identified the test substance as follows:
· batch number:
- protocol and labelling: 110-9502-34
description: whitish powder
quantity and container: 2 plastic bags containing each 0.1 kg
date of receipt: 18.5.95
storage conditions: at room temperature and protected from light
purity: 99.7%.
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Animals
Species and strain: Dunkin-Hartley guinea-pigs.
Reason for this choice: species recommended by the international regulations for sensitization
studies. The strain used has been shown to produce a satisfactory sensitization response using
known positive sensitizers.
Number: 30 animals (15 males and 15 nulliparous and non-pregnant females).
Allocation of the animals to the groups: on day -1, the animals were weighed and randomly
allocated to two groups: a control group 1 consisting of ten animals (five males and
five females) and a treated group 2 consisting of 20 animals (ten males and ten females).
Weight: on day 1, the animals were approximately three months old and had a mean body
weight ± standard deviation of 353 ± 26 g for the males and 339 ± 21 g for the females.
Acclimatization: at least five days before the beginning of the study.
Identification of the animals: ear-tattoo.
Environmental conditions
During the acclimatization period and throughout the study, the conditions in the animal room
were set as follows:
temperature: 21 ± 2°C
relative humidity: 30 to 70%
light/dark cycle: 12 h/12 h
ventilation: about 12 cycles/hour of filtered, non-recycled air.
The temperature and relative humidity were recorded continuously and records retained.
The housing conditions (temperature, relative humidity, light/dark cycle and ventilation) were
checked regularly.
During the acclimatization period and throughout the study, the animals were housed
individually in polycarbonate cages (48 cm x 27 cm x 20 cm) equipped with a polypropylene
bottle.
Dust-free sawdust was provided as litter (SICSA, 92142 Alfortville, France).
Bacteriological analysis of the sawdust and detection of possible contaminants (pesticides,
heavy metals) are performed periodically.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- paraffin oil
- Concentration / amount:
- Induction (treated group)
intradermal injections: DILAUROYL PEROXIDE at I% (w/w) in paraffin oil.
. topical application: DILAUROYL PEROXIDE at 20% (w/w) in paraffin oil.
Challenge Call groups)
. topical application: DILAUROYL PEROXIDE at 1% (w/w) in paraffin oil.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- Induction (treated group)
intradermal injections: DILAUROYL PEROXIDE at I% (w/w) in paraffin oil.
. topical application: DILAUROYL PEROXIDE at 20% (w/w) in paraffin oil.
Challenge Call groups)
. topical application: DILAUROYL PEROXIDE at 1% (w/w) in paraffin oil.
- No. of animals per dose:
- Thirty guinea-pigs were allocated to two groups: a control group 1 (five males and five females)
and a treated group 2 (ten males and ten females). - Details on study design:
- On day 1, in the dorsal region between the shoulders, intradermal injections of Freund's
complete adjuvant mixed with the test substance (treated group) or the vehicle (control group)
were prepared.
On day 8, this same test site was treated by topical application of the test substance (treated
group) or the vehicle (control group) and was covered by an occlusive dressing for 48 hours.
After a rest period of 12 days, all animals of the treated and control groups were challenged by a
topical application of the test substance to the right flank. The left flank served as control and
received the vehicle only.
Test substance and vehicle were maintained under an occlusive dressing for 24 hours. Skin
reactions were evaluated approximately 24 and 48 hours later.
Twenty-four and 48 hours after the challenge application, both flanks of the treated and control
animals were observed in order to evaluate cutaneous reactions, according to the following
scale:
Erythema and eschar formation
· No erythema....................................................................................................................... 0
· Very slight erythema (barely perceptible) ......................................................................1
· Well-defined erythema ......................................................................................................2
· Moderate to severe erythema ..........................................................................................3
· Severe erythema (beet redness) to slight eschar formation (injuries in depth)...... 4
Oedema formation
· No oedema............................................................................................................................ 0
· Very slight oedema (barely perceptible)........................................................................... 1
· Slight oedema (visible swelling with well-defined edges).............................................. 2
· Moderate oedema (visible swelling raised more than I millimetre) ..............................3
· Severe oedema (visible swelling raised more than 1 millimetre and extending
beyond the area of exposure) .............................................................................................4
Any other lesions were noted.
CLINICAL EXAMINATIONS
The animals were observed twice a day during the study in order to check for clinical signs and
mortality.
BODY WEIGHT
The animals were weighed individually on the day of allocation into the groups, on the first day
of the study (day 1), on days 8 and 15 and on the last day of the study.
PATHOLOGY
Necropsy
At the end of the study, all the animals were killed by CO2 inhalation in excess. No necropsy
was performed.
Cutaneous samples
No skin samples were taken.
Microscopic examination
No histological examinations were performed.
The treated animals show a positive reaction if macroscopic cutaneous reactions are clearly
visible (erythema ~ 2) and if the treated animals have a greater intensity or duration of response
than the maximum reaction seen in control animals, or, if macroscopic reactions are confirmed
at microscopic examination as being due to the sensitization process. Sensitization reactions are
characterized at microscopic examination by basal spongiosis, reactional acanthosis of the
epidermis and infiltration of mononucleated cells into the dermis (I).
% of animals Allergenicity Classification
showing a reaction level
o - 8 I very weak
9 - 28 II weak
29 - 64 III moderate
65 - 80 IV strong
81 - 100 V very strong
According to the Commission Directive 93121/E.E.C., when the reactions are positive in at least
30% of the treated animals, the test substance has sensitization properties and the sentence
"R 43: May cause sensitization by skin contact" must be applied. - Challenge controls:
- Control groups were challenged by a topical application of the test substance to the right flank.
- Positive control substance(s):
- yes
- Remarks:
- 2,4-dinitro chlorobenzene
Results and discussion
- Positive control results:
- Under our experimental conditions and according to the Magnusson and Kligman method,
2,4-dinitro chlorobenzene at a concentration of 1% (w/w) induced positive skin sensitization
reactions in 100% of the guinea-pigs.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1% in paraffin oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 1% in paraffin oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: None.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1% in paraffin oil
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 1% in paraffin oil. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: None.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1% in paraffin oil
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 1% in paraffin oil. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: None.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1% in paraffin oil
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- None
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 1% in paraffin oil. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: None.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 1%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 1% . No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: None reported.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 1%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 1%. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: None reported.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the experimental conditions and according to the maximization method of Magnusson
and Kligman, no cutaneous reactions attributable to the sensitization potential of the test
substance DILAUROYL PEROXIDE were observed in guinea-pigs. - Executive summary:
The potential of the test substance DILAUROYL PEROXIDE to induce delayed contact hypersensitivity was evaluated in guinea-pigs according to the maximization method of Magnusson and Kligman and to O.E.C.D. (No. 406, 17th July 1992) and E.C. (92/69/E.E.C., B6) guidelines. The study was conducted in compliance with the principles of Good Laboratory Practice Regulations. Methods Thirty guinea-pigs were allocated to two groups: a control group 1 (five males and five females) and a treated group 2 (ten males and ten females). On day 1, in the dorsal region between the shoulders, intradermal injections of Freund's complete adjuvant mixed with the test substance (treated group) or the vehicle (control group) were prepared. On day 8, this same test site was treated by topical application of the test substance (treated group) or the vehicle (control group) and was covered by an occlusive dressing for 48 hours. After a rest period of 12 days, all animals of the treated and control groups were challenged by a topical application of the test substance to the right flank. The left flank served as control and received the vehicle only. Test substance and vehicle were maintained under an occlusive dressing for 24 hours. Skin reactions were evaluated approximately 24 and 48 hours later. Test substance concentrations were as follows:
Induction (treated group)
intradermal injections: DILAUROYL PEROXIDE at I% (w/w) in paraffin oil.
topical application: DILAUROYL PEROXIDE at 20% (w/w) in paraffin oil.
Challenge Call groups) .
topical application: DILAUROYL PEROXIDE at 1% (w/w) in paraffin oil.
At the end of the study, animals were killed. No skin samples were taken from the challenge application sites.
The sensitivity of the guinea-pigs in C.LT. experimental conditions were checked in a recent study with a positive sensitizer: 2,4-dinitro chlorobenzene. During induction period, the test substance was applied at 0.1% (day 1) and 1% (day 8) concentrations. At cutaneous challenge application, 1% (w/w) was tested on the right flank
No clinical signs and no deaths were noted during the study. No cutaneous reactions were observed after the challenge application. The guinea-pigs which were used in a recent study, showed a satisfactory sensitization response in 100% animals using a positive sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.